Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Ixekizumab

Drug-induced enterocolitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Saito K, et al. Drug-induced entero-colitis due to interleukin-17 inhibitor use; capsule endoscopic findings and pathological characteristics: A case report. World Journal of Gastroenterology 29: 4912-4919, No. 32, Aug 2023. Available from: URL: http://doi.org/10.3748/wjg.v29.i32.4912 Saito K, et al. Drug-induced entero-colitis due to interleukin-17 inhibitor use; capsule endoscopic findings and pathological characteristics: A case report. World Journal of Gastroenterology 29: 4912-4919, No. 32, Aug 2023. Available from: URL: http://​doi.​org/​10.​3748/​wjg.​v29.​i32.​4912
Metadaten
Titel
Ixekizumab
Drug-induced enterocolitis: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-48415-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Methotrexate

Case report

Antibacterials

Case report

Thalidomide

Case report

Multiple drugs